Pulsatile Tinnitus (Vascular-Origin Subtype)
Investigational use for pulsatile vascular-origin tinnitus distinct from subjective tinnitus; no clinical study of leech therapy for this subtype was identified.
Patient Summary
- Is this FDA-cleared for this use?
- Not FDA-cleared for pulsatile tinnitus of vascular origin. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, June 2004). Use here is Tier C investigational.
- What evidence exists?
- No published clinical study of leech therapy could be verified for this condition. Tier C (investigational). Pulsatile tinnitus is a symptom requiring imaging workup, not a primary diagnosis. Evidence-based first-line management is identifying and treating the underlying cause (dural arteriovenous fistula, sigmoid sinus diverticulum, carotid stenosis, idiopathic intracranial hypertension) via MRA/CTA and neurosurgical, interventional radiology, or ENT-directed therapy.
- Main risks
- Bleeding from each bite site for 6 to 10 hours after the leech detaches
- Iron-deficiency anemia from cumulative blood loss across multiple sessions
- Aeromonas hydrophila wound infection from leech gut bacteria (uncommon outside reconstructive surgery, but possible)
- Allergic reaction to leech saliva (rare; ranges from local itching to anaphylaxis)
- Small Y-shaped bite marks or skin colour changes at the bite sites, which usually fade over weeks to months
- Local pain, bruising, swelling, or itching for 1 to 3 days after each session
- Who should not consider this
- Patients who have not had imaging workup (MRA/MRV/CTA) — a treatable vascular lesion may be missed
- Patients with a known carotid dissection, carotid stenosis, dural AV fistula, or intracranial aneurysm
- Anyone on blood thinners such as warfarin, apixaban, rivaroxaban, dabigatran or heparin (daily aspirin alone is not a contraindication: tell your doctor, who starts with fewer leeches)
- People with hemophilia or any other inherited bleeding disorder
- Patients with anemia
- People with an active infection at the planned application site
- Patients who are pregnant (leech therapy is not done during pregnancy) or breastfeeding (discuss it with your doctor)
- What to ask your clinician
- Have I had MRA, MRV, or CTA to look for a treatable cause of the pulsing sound?
- Has an ENT or neurosurgeon ruled out structural problems like a sigmoid sinus diverticulum?
- If a cause is found, would catheter-based or surgical treatment cure the tinnitus completely?
- What is the expected response rate and how would success be measured?
- Could the leech therapy mask worsening of a serious vascular cause?
- What are non-invasive options like sound therapy or CBT for tinnitus distress?
- When to seek urgent care
- Bleeding from a bite site that soaks through more than one dressing per hour
- Bleeding that continues more than 24 hours after the leech detached
- Spreading redness, warmth, swelling, pus, or red streaks around any bite site
- Fever over 38.0 C / 100.4 F, chills, or feeling suddenly unwell after a session
- Hives, facial or tongue swelling, throat tightness, or any difficulty breathing
- Sudden weakness, dizziness, fast heart rate, or fainting (possible severe blood loss)
- Sudden hearing loss, severe headache, facial weakness, slurred speech, or vision changes
What this does NOT mean
- It does not mean leech therapy is FDA-cleared for pulsatile tinnitus — the only FDA clearance is venous congestion in microsurgical reconstruction (K040187, June 2004).
- It does not replace imaging workup — pulsatile tinnitus can be the first sign of treatable vascular pathology that requires endovascular or surgical repair.
- No RCT or case series of leech therapy for pulsatile tinnitus was identified, so no clinical evidence of efficacy for this subtype was found.
- It does not address most causes of pulsatile tinnitus, which are anatomic rather than inflammatory.
- It does not work for non-pulsatile (continuous) tinnitus, which has a different physiology.
Safety cross-references
Clinical Profile
- Category
- ENT
- ICD-10
- H93.A1, H93.A2, H93.A3, H93.A9
- Safety tier
- Medium
Evidence Summary
Pulsatile tinnitus has an identifiable vascular substrate in the majority of cases (sigmoid sinus diverticulum, idiopathic intracranial hypertension, atherosclerotic carotid disease). No clinical study of leech therapy specific to pulsatile tinnitus was identified in PubMed, Europe PMC, Crossref or Russian-language sources. The few clinical reports on leeches in tinnitus concern tinnitus with sensorineural hearing loss or other inner-ear disease (uncontrolled or non-randomized series, e.g., Senchukova & Nikulina 2013) and do not address vascular-origin pulsatile tinnitus; any use is investigational. Structural causes must be excluded by MR venography or CT angiography before any complementary intervention is even considered. Hirudotherapy is not a substitute for definitive vascular treatment when an anatomic lesion is identified.
What the books describe
Below is a summary of what books on hirudotherapy say about this condition. These are the authors’ observations, not a proven effect and not a promise of results. Hirudotherapy has contraindications; the decision is made by a physician.
- Baskova and Isakhanyan do not write specifically about pulsatile noise in the ears of vascular origin: they speak of noises in the ear in chronic neuritis of the auditory nerves, which are included in the list of indications for hirudotherapy in otorhinolaryngology[B1].
- Michalsen et al. likewise do not write separately about pulsatile tinnitus: the chapter on indications (Flecken and Michalsen) speaks of tinnitus in general, which the authors call a syndrome that is difficult to treat and of unclear origin[B3].
- According to the same authors, the data on hirudotherapy in tinnitus are not sufficient for an objective assessment of the treatment response, the mechanism of action is unclear, and an unspecific effect (a placebo effect) cannot be ruled out[B3].
- Michalsen, in the chapter on the scientific basis, asks for caution with the results of the study by Baskova’s team on tinnitus (in his reference list this is the work of Seleznev et al., 1992); he notes that reports of the good effects of leeches in tinnitus are frequently heard in practice, and considers clinical studies on this subject highly desirable[B3].
- Baskova and Isakhanyan cite material by Grigoriev and Krymskaya (1998) on 40 patients with sensorineural cochleovestibular (hearing and balance) disorders of predominantly peripheral origin: circulatory disturbances there were linked to hypertensive disease, atherosclerosis and changes in the properties of the blood, and after treatment, as stated, all patients noted a lightness in the head and the noise indicators decreased; whether the noise was pulsatile is not clear from the text[B1].
- Among the contraindications to hirudotherapy, Baskova and Isakhanyan name hemophilia, hemorrhagic diatheses, anemias and concurrent prescription of anticoagulants (their list is longer); Flecken and Michalsen, in the chapter on contraindications, regard congenital or acquired hemophilia and taking anticoagulants as an absolute contraindication, and in anemia, in their words, treatment involving blood removal is generally contraindicated[B1][B3].
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)
Contraindications
- Hemophilia or another bleeding disorder
- Taking anticoagulants (blood thinners such as warfarin or heparin)
- Anemia or suppressed blood formation
- Low blood pressure, shock, collapse or fainting
- Severe wasting (cachexia)
- Intolerance of leeches or a history of severe allergic reactions
- Pregnancy
- Stomach or duodenal ulcer, erosive gastritis
- Acute infectious disease or high fever
- Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
- Drinking alcohol at the time of treatment
- No consent from the patient
- Active deep vein thrombosis (acute phase)
- Critical limb ischemia (ABI <0.4)
- Untreated structural vascular lesion (dural fistula, sinus stenosis, carotid stenosis)
- Active middle ear infection
Related Conditions
Subjective Tinnitus
Investigational for tinnitus; small non-randomized studies, mostly Russian, report less ear noise, and no study using the Tinnitus Handicap Inventory was identified.
Ménière's Disease (Adjunctive)
Investigational adjunct for Ménière's disease with no clinical study identified; standard management (diet, betahistine, intratympanic therapy) remains primary.
Chronic Rhinosinusitis
Investigational use for chronic rhinosinusitis; no clinical study of leech therapy for this condition was identified, and the rationale is mechanistic.
Peripheral Vertigo (BPPV-Refractory / Vestibular Neuritis Recovery)
Investigational adjunct for peripheral vertigo persisting after Epley maneuvers or during prolonged vestibular neuritis recovery; no study specific to these conditions was identified.
References
- [B1]
Баскова И.П., Исаханян Г.С. Гирудотерапия. Наука и практика [Hirudotherapy: Science and Practice]
Monograph in Russian, 506 pp., ISBN 5-89527-058-1. Chapter 15: sensation at the bite, length of the session; secretion kininases and pain.
- [B3]
Michalsen A., Roth M., Dobos G. Medicinal Leech Therapy
ISBN 978-3-13-143581-1 / 978-1-58890-563-5. Chapter 9, p. 107: perceptions of the bite — a local dragging pain lasting around one to five minutes.
The information on this page is based on the hirudotherapy books listed under References and reflects the experience their authors describe. Sensations and results differ from person to person. This information is not medical advice, a diagnosis or a prescription, and it does not replace an examination by a physician. Do not stop or change any prescribed treatment without your physician. Hirudotherapy has contraindications.